Aspirin-triggered lipoxin A4 and B4 analogs block extracellular signal-regulated kinase-dependent TNF-α secretion from human T cells

Journal of Immunology

Volumn 170, Issue 12, 2003, Pages 6266-6272

  Ariel, Amiram ^a   Chiang, Nan ^a   Arita, Makoto ^a   Petasis, Nicos A ^b   Serhan, Charles N ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOXIN A; LIPOXIN B; MITOGEN ACTIVATED PROTEIN KINASE; MONOCLONAL ANTIBODY CD3; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CYTOKINE RELEASE; ENZYME ACTIVATION; ENZYME ANALYSIS; HUMAN; HUMAN CELL; IC 50; IMMUNE SYSTEM; INFLAMMATION; LYMPHOCYTE FUNCTION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; REGULATORY MECHANISM; T LYMPHOCYTE;

EID: 0038280022     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.12.6266     Document Type: Article

References (46)

1. Graler, M. H., and E. J. Goetzl. 2002. Lysophospholipids and their G protein-coupled receptors in inflammation and immunity. Biochim. Biophys. Acta 1582:168.
2. Hla, T., M. J. Lee, N. Ancellin, J. H. Paik, and M. J. Kluk. 2001. Lysophospholipids - receptor revelations. Science 294:1875.
3. Costabile, M., C. S. Hii, B. S. Robinson, D. A. Rathjen, M. Pitt, C. Easton, R. C. Miller, A. Poulos, A. W. Murray, and A. Ferrante. 2001. A novel long chain polyunsaturated fatty acid, β-Oxa 21:3n-3, inhibits T lymphocyte proliferation, cytokine production, delayed-type hypersensitivity, and carrageenan-induced paw reaction and selectively targets intracellular signals. J. Immunol. 167:3980.
4. Myers, L. K., A. H. Kang, A. E. Postlethwaite, E. F. Rosloniec, S. G. Morham, B. V. Shlopov, S. Goorha, and L. R. Ballou. 2000. The genetic ablation of cyclooxygenase 2 prevents the development of autoimmune arthritis. Arthritis Rheum. 43:2687.
5. Backlund, J., S. Carlsen, T. Hoger, B. Holm, L. Fugger, J. Kihlberg, H. Burkhardt, and R. Holmdahl. 2002. Predominant selection of T cells specific for the glycosylated collagen type II epitope (263-270) in humanized transgenic mice and in rheumatoid arthritis. Proc. Natl. Acad. Sci. USA 2002:27.
6. 4 and PAF in the cytokine network. In Cell-Cell Interactions in the Release of Inflammatory Mediators, Vol. 314. P. Wong, and C. N. Serhan, eds. Plenum, New York, p. 205.
7. Payan, D. G., A. Missirian-Bastian, and E. J. Goetzl. 1984. Human T-lymphocyte subset specificity of the regulatory effects of leukotriene B4. Proc. Natl. Acad. Sci. USA 81:3501.
8. Serhan, C. N., and E. Oliw. 2001. Unorthodox routes to prostanoid formation: new twists in cyclooxygenase-initiated pathways. J. Clin. Invest. 107:1481.
9. Chavis, C., I. Vachier, P. Chanez, J. Bousquet, and P. Godard. 1996. 5(S),15(S)-dihydroxyeicosatetraenoic acid and lipoxin generation in human polymorphonuclear cells: dual specificity of 5-lipoxygenase towards endogenous and exogenous precursors. J. Exp. Med. 183:1633.
10. Levy, B. D., C. B. Clish, B. Schmidt, K. Gronert, and C. N. Serhan. 2001. Lipid mediator class switching during acute inflammation: signals in resolution. Nat. Immunol. 2:612.
11. Aliberti, J., S. Hieny, C. Reis e Sousa, C. N. Serhan, and A. Sher. 2002. Lipoxinmediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity. Nat. Immunol. 3:76.
12. 4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors. J. Exp. Med. 185:1693.
13. Clish, C. B., J. A. O'Brien, K. Gronert, G. L. Stahl, N. A. Petasis, and C. N. Serhan. 1999. Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo. Proc. Natl. Acad. Sci. USA 96:8247.
14. 4 modulates in vivo expression of delayed-type hypersensitivity by a receptor-mediated mechanism: regulation by lipoxin A4. J. Pharmacol. Exp. Ther. 278:950.
15. 4 analogs attenuate induction of intestinal epithelial proinflammatory gene expression and reduce the severity of dextran sodium sulfate-induced colitis. J. Immunol. 168:5260.
16. Bonnans, C., I. Vachier, C. Chavis, P. Godard, J. Bousquet, and P. Chanez. 2002. Lipoxins are potential endogenous antiinflammatory mediators in asthma. Am J. Respir. Crit. Care Med. 165:1531.
17. Mazzeo, D., P. Panina-Bordignon, H. Recalde, F. Sinigaglia, and D. D'Ambrosio. 1998. Decreased IL-12 production and Th1 cell development by acetyl salicylic acid-mediated inhibition of NF-κB. Eur. J. Immunol. 28:3205.
18. O'Shea, J. J., A. Ma, and P. Lipsky. 2002. Cytokines and autoimmunity. Nat. Rev. Immunol. 2:37.
19. Pimentel-Muinos, F. X., M. A. Munoz-Fernandez, and M. Fresno. 1994. Control of T lymphocyte activation and IL-2 receptor expression by endogenously secreted lymphokines. J. Immunol. 152:5714.
20. Ji, H., A. Pettit, K. Ohmura, A. Ortiz-Lopez, V. Duchatelle, C. Degott, E. Gravallese, D. Mathis, and C. Benoist. 2002. Critical roles for interleukin and tumor necrosis factor a in antibody-induced arthritis. J. Exp. Med. 196:77.
21. Feldmann, M. 2002. Development of anti-TNF therapy for rheumatoid arthritis. Nat. Rev. Immunol. 2:364.
22. Mayordomo, L., J. L. Marenco, J. Gomez-Mateos, and E. Rejon. 2002. Pulmonary miliary tuberculosis in a patient with anti-TNF-α treatment. Scand. J. Rheumatol. 31:44.
23. 4 stable analogs that block transmigration and adhesion of human neutrophils. Biochemistry 34:14609.
24. 4 analogs with increased biologic activity. FASEB J. 12:487.
25. Ariel, A., D. Novick, M. Rubinstein, C. A. Dinarello, O. Lider, and R. Hershkoviz. 2002. IL-12 and IL-18 induce MAP kinase-dependent adhesion of T cells to extracellular matrix components. J. Leukocyte Biol. 72:192.
26. Arita, M., K. Nomura, H. Arai, and K. Inoue. 1997. α-Tocopherol transfer protein stimulates the secretion of α-tocopherol from a cultured liver cell line through a brefeldin A-insensitive pathway. Proc. Natl. Acad. Sci. USA 94:12437.
27. 4 receptor. J. Biol. Chem. 272:6972.
28. Rommel, C., B. A. Clarke, S. Zimmermann, L. Nunez, R. Rossman, K. Reid, K. Moelling, G. D. Yancopoulos, and D. J. Glass. 1999. Differentiation stagespecific inhibition of the Raf-MEK-ERK pathway by Akt. Science 286:1738.
29. + peripheral blood lymphocytes. J. Immunol. 149:3278.
30. Hebert, M. J., T. Takano, H. Holthofer, and H. R. Brady. 1996. Sequential morphologic events during apoptosis of human neutrophils: modulation by lipoxygenase-derived eicosanoids. J. Immunol. 157:3105.
31. 2+ mobilization. J. Immunol. 157:2149.
32. 4 receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation. J. Exp. Med. 191:1197.
33. 4 receptor. J. Exp. Med. 180:253.
34. Mariathasan, S., A. Zakarian, D. Bouchard, A. M. Michie, J. C. Zuniga-Pflucker, and P. S. Ohashi. 2001. Duration and strength of extracellular signal-regulated kinase signals are altered during positive versus negative thymocyte selection. J. Immunol. 167:4966.
35. Favata, M. F., K. Y. Horiuchi, E. J. Manos, A. J. Daulerio, D. A. Stradley, W. S. Feeser, D. E. Van Dyk, W. J. Pitts, R. A. Earl, F. Hobbs, et al. 1998. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273:18623.
36. Koprak, S., M. J. Staruch, and F. J. Dumont. 1999. A specific inhibitor of the p38 mitogen activated protein kinase affects differentially the production of various cytokines by activated human T cells: dependence on CD28 signaling and preferential inhibition of IL-10 production. Cell Immunol. 192:87.
37. Akazawa, A., I. Sakaida, S. Higaki, Y. Kubo, K. Uchida, and K. Okita. 2002. Increased expression of tumor necrosis factor-α messenger RNA in the intestinal mucosa of inflammatory bowel disease, particularly in patients with disease in the inactive phase. J. Gastroenterol. 37:345.
38. Kollias, G., D. Kontoyiannis, E. Douni, and G. Kassiotis. 2002. The role of TNF/TNFR in organ-specific and systemic autoimmunity: implications for the design of optimized "anti-TNF' therapies. Curr. Dir. Autoimmun. 5:30.
39. Kassiotis, G., and G. Kollias. 2001. Uncoupling the proinfiammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: implications for pathogenesis and therapy of autoimmune demyelination. J. Exp. Med. 193:427.
40. 4 receptor that is regulated by interleukin (IL)-13 and interferon gamma and inhibits tumor necrosis factor alpha-induced IL-8 release. J. Exp. Med. 187:1285.
41. Resnati, M., I. Pallavicini, J. M. Wang, J. Oppenheim, C. N. Serhan, M. Romano, and F. Blasi. 2002. The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRLI/LXA4R. Proc. Natl. Acad. Sci. USA 99:1359.
42. 4 inhibits IL-1 β-induced IL-6, IL-8, and matrix metalloproteinase-3 production in human synovial fibroblasts and enhances synthesis of tissue inhibitors of metalloproteinases. J. Immunol. 164:2660.
43. McMahon, B., S. Mitchell, H. R. Brady, and C. Godson. 2001. Lipoxins: revelations on resolution. Trends Pharmacol. Sci. 22:391.
44. 4 up-regulate transcriptional corepressor NAB1 in human neutrophils. FASEB J. 15:2736.
45. 4, is protective in experimental ischemic acute renal failure. J. Am. Soc. Nephrol. 13:1657.
46. 4 in human renal mesangial cells: differential activation of MAP kinases through distinct receptors. J. Biol. Chem. 275:27566.